EU Regulatory Review – What Pharma Should Remember From 2017
Executive Summary
You could be forgiven for thinking that Brexit was the only story in town on the European regulatory front in 2017, but there were of course plenty of other important developments during the year.
You may also be interested in...
2017 – Scrip Readers’ Pharma Year In Review
As we enter a new year, Scrip reviews some of the biggest overall themes which attracted our readers over the last 12 months.
2017 – Scrip Readers’ Pharma Year In Review
As we enter a new year, Scrip reviews some of the biggest overall themes which attracted our readers over the last 12 months.
EMA's Proposal To Disclose Key Elements Of Pediatric Plans On Hold For Now
A year after the European Medicines Agency announced plans to publicly disclose the key elements of pediatric investigation plans to make its regulatory decisions more transparent, concerns around confidentiality issues and resources means no final decision has yet been made on the implementation of this controversial proposal.